View ValuationSunstone Development 향후 성장Future 기준 점검 2/6Sunstone Development (는) 각각 연간 20.3% 및 14.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 20% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 15.8% 로 예상됩니다.핵심 정보20.3%이익 성장률19.97%EPS 성장률Chemicals 이익 성장30.0%매출 성장률14.5%향후 자기자본이익률15.80%애널리스트 커버리지Low마지막 업데이트07 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 23Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China공시 • Mar 30Sunstone Development Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026Sunstone Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026공시 • Dec 26Sunstone Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026Sunstone Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026공시 • Sep 30Sunstone Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025Sunstone Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025공시 • Jun 30Sunstone Development Co., Ltd. to Report First Half, 2025 Results on Aug 21, 2025Sunstone Development Co., Ltd. announced that they will report first half, 2025 results on Aug 21, 2025공시 • Apr 23Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China공시 • Mar 28Sunstone Development Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025Sunstone Development Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025공시 • Dec 27Sunstone Development Co., Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025Sunstone Development Co., Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.15 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.32 (up from CN¥0.15 in 3Q 2023). Revenue: CN¥3.44b (down 9.4% from 3Q 2023). Net income: CN¥185.3m (up 141% from 3Q 2023). Profit margin: 5.4% (up from 2.0% in 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.공시 • Sep 30Sunstone Development Co., Ltd. to Report Q3, 2024 Results on Oct 24, 2024Sunstone Development Co., Ltd. announced that they will report Q3, 2024 results on Oct 24, 2024공시 • Sep 25Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd.Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. for approximately 300 million on July 27, 2024. The transaction is subject to approval by regulatory board / committee. Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. on September 24, 2024.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.28 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.28 loss in 2Q 2023). Revenue: CN¥3.37b (down 14% from 2Q 2023). Net income: CN¥73.8m (up CN¥209.4m from 2Q 2023). Profit margin: 2.2% (up from net loss in 2Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.공시 • Jun 28Sunstone Development Co., Ltd. to Report First Half, 2024 Results on Aug 21, 2024Sunstone Development Co., Ltd. announced that they will report first half, 2024 results on Aug 21, 2024Reported Earnings • May 01Full year 2023 earnings released: CN¥1.40 loss per share (vs CN¥1.97 profit in FY 2022)Full year 2023 results: CN¥1.40 loss per share (down from CN¥1.97 profit in FY 2022). Revenue: CN¥15.3b (down 21% from FY 2022). Net loss: CN¥722.7m (down 180% from profit in FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.공시 • May 01Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing ChinaBoard Change • Apr 26Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hao Sun was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Buy Or Sell Opportunity • Feb 21Now 21% overvaluedOver the last 90 days, the stock has fallen 34% to CN¥11.46. The fair value is estimated to be CN¥9.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making.공시 • Dec 29Sunstone Development Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Sunstone Development Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Oct 30Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.87 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.87 in 3Q 2022). Revenue: CN¥3.80b (down 34% from 3Q 2022). Net income: CN¥76.8m (down 81% from 3Q 2022). Profit margin: 2.0% (down from 6.9% in 3Q 2022). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.New Risk • Oct 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding).공시 • Jun 28Sunstone Development Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Sunstone Development Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥1.97 (vs CN¥1.40 in FY 2021)Full year 2022 results: EPS: CN¥1.97 (up from CN¥1.40 in FY 2021). Revenue: CN¥19.4b (up 105% from FY 2021). Net income: CN¥905.2m (up 46% from FY 2021). Profit margin: 4.7% (down from 6.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥32.80, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 249% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.32 per share.Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥0.87 (vs CN¥0.41 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.87 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥5.75b (up 114% from 3Q 2021). Net income: CN¥397.0m (up 118% from 3Q 2021). Profit margin: 6.9% (up from 6.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to CN¥30.75, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.97 per share.Reported Earnings • Aug 31Second quarter 2022 earnings released: EPS: CN¥0.89 (vs CN¥0.42 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥4.78b (up 114% from 2Q 2021). Net income: CN¥409.7m (up 125% from 2Q 2021). Profit margin: 8.6% (up from 8.2% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 66%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥36.97, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 253% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥54.47 per share.Buying Opportunity • Jul 19Now 23% undervaluedOver the last 90 days, the stock is up 119%. The fair value is estimated to be CN¥56.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 39% over the last 3 years. Earnings per share has grown by 66%. Revenue is forecast to grow by 119% in 2 years. Earnings is forecast to grow by 124% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥43.63, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 299% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥56.38 per share.Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥37.80, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 270% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥51.82 per share.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥29.18, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 183% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥48.60 per share.Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.34 (vs CN¥0.25 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.34 (up from CN¥0.25 in 1Q 2021). Revenue: CN¥3.19b (up 88% from 1Q 2021). Net income: CN¥158.1m (up 44% from 1Q 2021). Profit margin: 5.0% (down from 6.5% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 44%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 16Full year 2021 earnings released: EPS: CN¥1.40 (vs CN¥0.59 in FY 2020)Full year 2021 results: EPS: CN¥1.40 (up from CN¥0.59 in FY 2020). Revenue: CN¥9.46b (up 62% from FY 2020). Net income: CN¥620.0m (up 190% from FY 2020). Profit margin: 6.6% (up from 3.7% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 32%, compared to a 51% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.53, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.68b (up 90% from 3Q 2020). Net income: CN¥182.3m (up 232% from 3Q 2020). Profit margin: 6.8% (up from 3.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥24.94, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 69% over the past three years.Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥27.13, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥52.33 per share.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.14 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥2.23b (up 54% from 2Q 2020). Net income: CN¥181.7m (up 274% from 2Q 2020). Profit margin: 8.2% (up from 3.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥20.94, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years.Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.04 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.70b (up 43% from 1Q 2020). Net income: CN¥109.7m (up CN¥96.3m from 1Q 2020). Profit margin: 6.5% (up from 1.1% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥20.50, the stock trades at a trailing P/E ratio of 46.9x, up from the previous P/E ratio of 39.6x. Average P/E is 35x in the Chemicals industry in China. Total return to shareholders over the past three years was a loss of 37%.Is New 90 Day High Low • Mar 12New 90-day high: CN¥18.25The company is up 22% from its price of CN¥14.95 on 11 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.59 per share.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥16.37, the stock is trading at a trailing P/E ratio of 37.5x, up from the previous P/E ratio of 32.4x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 41%.Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥18.37, the stock is trading at a trailing P/E ratio of 38.2x, up from the previous P/E ratio of 32.9x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past year are 79%.Is New 90 Day High Low • Nov 18New 90-day high: CN¥15.95The company is up 5.0% from its price of CN¥15.24 on 20 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share.Valuation Update With 7 Day Price Move • Nov 10Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥14.63, the stock is trading at a trailing P/E ratio of 33.5x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 51%.Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS CN¥0.16The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥1.41b (up 27% from 3Q 2019). Net income: CN¥55.0m (up 114% from 3Q 2019). Profit margin: 3.9% (up from 2.3% in 3Q 2019). The increase in margin was driven by higher revenue.Is New 90 Day High Low • Oct 30New 90-day low: CN¥12.62The company is down 16% from its price of CN¥14.96 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share.이익 및 매출 성장 예측XSSC:603612 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202828,1181,2892,2502,146212/31/202724,4111,1551,7071,984212/31/202621,5499496661,33523/31/202618,674709-120509N/A12/31/202517,69374765712N/A9/30/202516,593710-35726N/A6/30/202515,581764-920-211N/A3/31/202514,386559-905-279N/A12/31/202413,750272-268426N/A9/30/202413,300-1741971,078N/A6/30/202413,656-2831,0061,999N/A3/31/202414,194-4925551,807N/A12/31/202315,311-7233521,651N/A9/30/202317,621-392-360878N/A6/30/202319,567-71-393810N/A3/31/202320,437474-95693N/A12/31/202219,401905-1,308-342N/A9/30/202216,5601,111-1,822-1,488N/A6/30/202213,495897-2,726-2,260N/A3/31/202210,945669-1,898-1,327N/A12/31/20219,458620-1,880-1,193N/A9/30/20218,418571-1,482-234N/A6/30/20217,148444-1,169-97N/A3/31/20216,364310-1,258-393N/A12/31/20205,851214-326343N/A9/30/20205,457145-112456N/A6/30/20205,15711517298N/A3/31/20204,69592-9125N/A12/31/20194,37286N/A-215N/A9/30/20193,77590N/A-336N/A6/30/20193,42489N/A-140N/A3/31/20193,296113N/A297N/A12/31/20183,354202N/A493N/A9/30/20183,546369N/A455N/A6/30/20183,635477N/A459N/A3/31/20183,577534N/A170N/A12/31/20173,281548N/A235N/A9/30/20172,912388N/A344N/A6/30/20172,643297N/A406N/A3/31/20172,230194N/AN/AN/A12/31/20161,96589N/A226N/A9/30/20161,77989N/A76N/A12/31/20151,728100N/A293N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 603612 의 연간 예상 수익 증가율(20.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 603612 의 연간 수익(20.3%)이 CN 시장(26.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 603612 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 603612 의 수익(연간 14.5%)이 CN 시장(연간 15.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 603612 의 수익(연간 14.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 603612의 자본 수익률은 3년 후 15.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/18 00:42종가2026/05/18 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sunstone Development Co., Ltd.는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jianfan ChenCitic Securities Co., Ltd.Mengluan LiuGuosen Securities Co., Ltd.Yijie WuHaitong International Research Limited
공시 • Apr 23Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China
공시 • Mar 30Sunstone Development Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026Sunstone Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026
공시 • Dec 26Sunstone Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026Sunstone Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026
공시 • Sep 30Sunstone Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025Sunstone Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025
공시 • Jun 30Sunstone Development Co., Ltd. to Report First Half, 2025 Results on Aug 21, 2025Sunstone Development Co., Ltd. announced that they will report first half, 2025 results on Aug 21, 2025
공시 • Apr 23Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China
공시 • Mar 28Sunstone Development Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025Sunstone Development Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025
공시 • Dec 27Sunstone Development Co., Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025Sunstone Development Co., Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025
Reported Earnings • Oct 24Third quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.15 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.32 (up from CN¥0.15 in 3Q 2023). Revenue: CN¥3.44b (down 9.4% from 3Q 2023). Net income: CN¥185.3m (up 141% from 3Q 2023). Profit margin: 5.4% (up from 2.0% in 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
공시 • Sep 30Sunstone Development Co., Ltd. to Report Q3, 2024 Results on Oct 24, 2024Sunstone Development Co., Ltd. announced that they will report Q3, 2024 results on Oct 24, 2024
공시 • Sep 25Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd.Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. for approximately 300 million on July 27, 2024. The transaction is subject to approval by regulatory board / committee. Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. on September 24, 2024.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.28 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.28 loss in 2Q 2023). Revenue: CN¥3.37b (down 14% from 2Q 2023). Net income: CN¥73.8m (up CN¥209.4m from 2Q 2023). Profit margin: 2.2% (up from net loss in 2Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.
공시 • Jun 28Sunstone Development Co., Ltd. to Report First Half, 2024 Results on Aug 21, 2024Sunstone Development Co., Ltd. announced that they will report first half, 2024 results on Aug 21, 2024
Reported Earnings • May 01Full year 2023 earnings released: CN¥1.40 loss per share (vs CN¥1.97 profit in FY 2022)Full year 2023 results: CN¥1.40 loss per share (down from CN¥1.97 profit in FY 2022). Revenue: CN¥15.3b (down 21% from FY 2022). Net loss: CN¥722.7m (down 180% from profit in FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
공시 • May 01Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China
Board Change • Apr 26Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hao Sun was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Buy Or Sell Opportunity • Feb 21Now 21% overvaluedOver the last 90 days, the stock has fallen 34% to CN¥11.46. The fair value is estimated to be CN¥9.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making.
공시 • Dec 29Sunstone Development Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Sunstone Development Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Oct 30Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.87 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.87 in 3Q 2022). Revenue: CN¥3.80b (down 34% from 3Q 2022). Net income: CN¥76.8m (down 81% from 3Q 2022). Profit margin: 2.0% (down from 6.9% in 3Q 2022). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
New Risk • Oct 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding).
공시 • Jun 28Sunstone Development Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Sunstone Development Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023
Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥1.97 (vs CN¥1.40 in FY 2021)Full year 2022 results: EPS: CN¥1.97 (up from CN¥1.40 in FY 2021). Revenue: CN¥19.4b (up 105% from FY 2021). Net income: CN¥905.2m (up 46% from FY 2021). Profit margin: 4.7% (down from 6.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥32.80, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 249% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.32 per share.
Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥0.87 (vs CN¥0.41 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.87 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥5.75b (up 114% from 3Q 2021). Net income: CN¥397.0m (up 118% from 3Q 2021). Profit margin: 6.9% (up from 6.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to CN¥30.75, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.97 per share.
Reported Earnings • Aug 31Second quarter 2022 earnings released: EPS: CN¥0.89 (vs CN¥0.42 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥4.78b (up 114% from 2Q 2021). Net income: CN¥409.7m (up 125% from 2Q 2021). Profit margin: 8.6% (up from 8.2% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 66%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥36.97, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 253% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥54.47 per share.
Buying Opportunity • Jul 19Now 23% undervaluedOver the last 90 days, the stock is up 119%. The fair value is estimated to be CN¥56.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 39% over the last 3 years. Earnings per share has grown by 66%. Revenue is forecast to grow by 119% in 2 years. Earnings is forecast to grow by 124% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥43.63, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 299% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥56.38 per share.
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥37.80, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 270% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥51.82 per share.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥29.18, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 183% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥48.60 per share.
Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.34 (vs CN¥0.25 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.34 (up from CN¥0.25 in 1Q 2021). Revenue: CN¥3.19b (up 88% from 1Q 2021). Net income: CN¥158.1m (up 44% from 1Q 2021). Profit margin: 5.0% (down from 6.5% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 44%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 16Full year 2021 earnings released: EPS: CN¥1.40 (vs CN¥0.59 in FY 2020)Full year 2021 results: EPS: CN¥1.40 (up from CN¥0.59 in FY 2020). Revenue: CN¥9.46b (up 62% from FY 2020). Net income: CN¥620.0m (up 190% from FY 2020). Profit margin: 6.6% (up from 3.7% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 32%, compared to a 51% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.53, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.16 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.68b (up 90% from 3Q 2020). Net income: CN¥182.3m (up 232% from 3Q 2020). Profit margin: 6.8% (up from 3.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥24.94, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 69% over the past three years.
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥27.13, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥52.33 per share.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.14 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥2.23b (up 54% from 2Q 2020). Net income: CN¥181.7m (up 274% from 2Q 2020). Profit margin: 8.2% (up from 3.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥20.94, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years.
Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.04 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.70b (up 43% from 1Q 2020). Net income: CN¥109.7m (up CN¥96.3m from 1Q 2020). Profit margin: 6.5% (up from 1.1% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥20.50, the stock trades at a trailing P/E ratio of 46.9x, up from the previous P/E ratio of 39.6x. Average P/E is 35x in the Chemicals industry in China. Total return to shareholders over the past three years was a loss of 37%.
Is New 90 Day High Low • Mar 12New 90-day high: CN¥18.25The company is up 22% from its price of CN¥14.95 on 11 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.59 per share.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥16.37, the stock is trading at a trailing P/E ratio of 37.5x, up from the previous P/E ratio of 32.4x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 41%.
Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥18.37, the stock is trading at a trailing P/E ratio of 38.2x, up from the previous P/E ratio of 32.9x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past year are 79%.
Is New 90 Day High Low • Nov 18New 90-day high: CN¥15.95The company is up 5.0% from its price of CN¥15.24 on 20 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share.
Valuation Update With 7 Day Price Move • Nov 10Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥14.63, the stock is trading at a trailing P/E ratio of 33.5x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 51%.
Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS CN¥0.16The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥1.41b (up 27% from 3Q 2019). Net income: CN¥55.0m (up 114% from 3Q 2019). Profit margin: 3.9% (up from 2.3% in 3Q 2019). The increase in margin was driven by higher revenue.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥12.62The company is down 16% from its price of CN¥14.96 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share.